CN103666886B - Pseudo-ginseng low-irritation skin care soap - Google Patents
Pseudo-ginseng low-irritation skin care soap Download PDFInfo
- Publication number
- CN103666886B CN103666886B CN201310096600.8A CN201310096600A CN103666886B CN 103666886 B CN103666886 B CN 103666886B CN 201310096600 A CN201310096600 A CN 201310096600A CN 103666886 B CN103666886 B CN 103666886B
- Authority
- CN
- China
- Prior art keywords
- pseudo
- ginseng
- soap
- sodium
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000344 soap Substances 0.000 title claims abstract description 46
- 244000131316 Panax pseudoginseng Species 0.000 title claims abstract description 41
- 235000003181 Panax pseudoginseng Nutrition 0.000 title claims abstract description 38
- 206010040880 Skin irritation Diseases 0.000 title claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 15
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 claims abstract description 6
- 229940082004 sodium laurate Drugs 0.000 claims abstract description 6
- JUQGWKYSEXPRGL-UHFFFAOYSA-M sodium;tetradecanoate Chemical compound [Na+].CCCCCCCCCCCCCC([O-])=O JUQGWKYSEXPRGL-UHFFFAOYSA-M 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 17
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 17
- -1 myristic amide propyl group amine Chemical class 0.000 claims description 15
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 claims description 12
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 239000003352 sequestering agent Substances 0.000 claims description 7
- PDIZYYQQWUOPPK-UHFFFAOYSA-N acetic acid;2-(methylamino)acetic acid Chemical compound CC(O)=O.CC(O)=O.CNCC(O)=O PDIZYYQQWUOPPK-UHFFFAOYSA-N 0.000 claims description 6
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 6
- 239000006260 foam Substances 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 2
- DKPKKUQZFWYBRB-UHFFFAOYSA-N n,n-dimethyl-3-(tetradecanoylamino)propan-1-amine oxide Chemical compound CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-] DKPKKUQZFWYBRB-UHFFFAOYSA-N 0.000 abstract description 2
- 229940045845 sodium myristate Drugs 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 9
- 239000003814 drug Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 238000004898 kneading Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229940120146 EDTMP Drugs 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- OHOTVSOGTVKXEL-WJXVXWFNSA-K trisodium;(2s)-2-[bis(carboxylatomethyl)amino]propanoate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)[C@H](C)N(CC([O-])=O)CC([O-])=O OHOTVSOGTVKXEL-WJXVXWFNSA-K 0.000 description 2
- BPSYZMLXRKCSJY-UHFFFAOYSA-N 1,3,2-dioxaphosphepan-2-ium 2-oxide Chemical compound O=[P+]1OCCCCO1 BPSYZMLXRKCSJY-UHFFFAOYSA-N 0.000 description 1
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001092371 Bergenia Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 235000001938 Citrus medica Nutrition 0.000 description 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 101100202589 Drosophila melanogaster scrib gene Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102100035792 Kininogen-1 Human genes 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- JNGWKQJZIUZUPR-UHFFFAOYSA-N [3-(dodecanoylamino)propyl](hydroxy)dimethylammonium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-] JNGWKQJZIUZUPR-UHFFFAOYSA-N 0.000 description 1
- QILXPCHTWXAUHE-UHFFFAOYSA-N [Na].NCCN Chemical compound [Na].NCCN QILXPCHTWXAUHE-UHFFFAOYSA-N 0.000 description 1
- OQRDSLOUOFIGSC-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na].NCCNCCN Chemical compound [Na].[Na].[Na].[Na].[Na].NCCNCCN OQRDSLOUOFIGSC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- RWIGWWBLTJLKMK-UHFFFAOYSA-N diethoxyphosphorylmethanol Chemical compound CCOP(=O)(CO)OCC RWIGWWBLTJLKMK-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940026210 lauramidopropylamine oxide Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HPEUEJRPDGMIMY-IFQPEPLCSA-N molybdopterin Chemical compound O([C@H]1N2)[C@H](COP(O)(O)=O)C(S)=C(S)[C@@H]1NC1=C2N=C(N)NC1=O HPEUEJRPDGMIMY-IFQPEPLCSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- WHNXAQZPEBNFBC-UHFFFAOYSA-K trisodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].OCCN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O WHNXAQZPEBNFBC-UHFFFAOYSA-K 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a pseudo-ginseng low-irritation skin care soap, comprising the following raw material in parts by weight: 0.05-0.15 part of pseudo-ginseng extract, 15-25 parts of sodium laurate, 50-70 parts of sodium myristate, 3-5 parts of dodecanoylamidopropylamine oxide, 3-5 parts of myristamidopropylamine oxide and 20 parts of water. The pseudo-ginseng low-irritation soap provided by the invention is fine and smooth and stable in foam, mild in nature, low in irritation to skin, and also capable of better moistening and caring the skin with the pseudo-ginseng extract.
Description
Technical field:
The present invention relates to a kind of perfumed soap, particularly a kind of Pseudo-ginseng low-irritation skin care soap.
Background technology:
Perfumed soap (soap) is one of skin, hair washing and nursing article, is a kind of daily necessities.Perfumed soap is with sodium soap and other tensio-active agents for main raw material, adds quality improver and appearance modifying agents, the product made after machine-shaping.
Perfumed soap is requisite washing and nursing article in daily life, with sodium soap and other tensio-active agents for main raw material, adds quality improver and appearance modifying agents, the product made after machine-shaping.The function of perfumed soap is clean washing, to be used in above skin that yes removes earth dirt, skin secretion, movement, chemical substance or bacterium etc., in the today stressing cosmetic result, removing the makeup of skin surface, skin care products or medicine is also one of its main purposes.
In the prior art, the Cake-shape soap of the many insights of perfumed soap to be fatty acid sodium salt be soap base, although have good cleaning force, whipability and easy washability, but not resistance to hard water, can produce incrustation scale during washing, form calcium magnesium soap, degreasing power is strong, the soap of human body life-time service meta-alkalescence can make skin feel dry and astringent, has excitement.
Pseudo-ginseng has another name called pseudo-ginseng, and the famous pharmacy man LI Shi-Zhen of the Ming Dynasty is called " invaluable ".Pseudo-ginseng is a jewel in Chinese medicinal materials, records in Qing Dynasty's pharmaceutical texts supplementary Amplifications of the Compendium of Materia Medica: " ginseng qi-tonifying the first, pseudo-ginseng enriches blood the first, taste with and merit also etc., therefore claiming Panax pseudoginseng, is the most precious person in Chinese medicine." become famous Chinese patent medicine " Yunnan white powder " at home and abroad and " sheet is young yellow ", be namely that main raw material is made with pseudo-ginseng.Pseudo-ginseng belongs to Araliaceae per nnial herb, adopts and long three petioles of every strain, raw seven blades of each petiole, therefore named pseudo-ginseng because it digs for after planting 3 to seven years.Its stem, leaf, Hua Junke are used as medicine.
English name: Sanch, Latin plant animal mineral name: Panax notoginseng (Burk.) F.H.Chen ex C.Chow, [P.pseudo-ginseng Wall.Vart.Notoginseng (Burk.) Hoo et Tseng].Section belongs to classification: Araliaceae.Another name: mountain paint, invaluable, blood ginseng, Panax pseudoginseng, Buddha's hand mountain paint, mountain paint, Radix Notoginseng, pseudo-ginseng, Yunnan pseudo-ginseng, rhizome of Scopulosus Bergenia.Nature and flavor: taste is sweet; Micro-hardship; Warm in nature.Gui Jing: return Liver Channel; Stomach warp; The heart channel of Hang-Shaoyin; Lung channel; Large intestine channel.Function: hemostasis; Loose blood; Analgesic therapy.
The pharmacological action of pseudo-ginseng:
Pseudo-ginseng has the hemostasis of the loose stasis of blood, effect of subduing swelling and relieving pain.Cure mainly spitting of blood, spit blood, bleeding from five sense organs or subcutaneous tissue, has blood in stool, uterine bleeding, traumatic hemorrhage, and chest ventral spine pain, falls servant and swell and ache.Compendium of Material Medica cloud: " pseudo-ginseng hemostatic, loose blood, analgesic therapy." " beautiful Chinese catalpa medicine solution " cloud: " pseudo-ginseng and battalion's hemostasis, the row stasis of blood of promoting blood circulation, row hemostasis and hold back new blood.”
One, stop blooding
The title that pseudo-ginseng has " stop blooding refreshing medicine ", loose hemostasis, hemostasis and do not stay the stasis of blood, to have the stagnant person of the stasis of blood concurrently more suitable to hemorrhage.Pseudo-ginseng has stronger anastalsis, and to different animals, different way of administration, different preparation, all shows obvious anastalsis.
Two, antithrombotic
Pseudo-ginseng has promoting blood circulation to remove blood stasis effect, energy platelet aggregation-against, antithrombus formation.Pseudo-ginseng anti-thrombosis function link includes platelet aggregation-against, antithrombin and promotion plasmin solution preocess.
Three, hematopoiesis is promoted
Pseudo-ginseng " promoting tissue regeneration by removing blood stasis ", modern study confirms that pseudo-ginseng has blood tonification effect.Radix Notoginseng injection significantly can promote the recovery of red corpuscle, reticulocyte, oxyphorase.
Four, to the effect of cardiovascular systems
Pseudo-ginseng falls apart the stasis of blood, and subduing swelling and relieving pain, PNS and other activeconstituentss have pharmacologically active to cardiovascular systems.
Five, anti-inflammatory
PNS is to histamine, acetic acid, dimethylbenzene, serotonin, and the capillary permeability that bradykinin etc. cause raises has obvious restraining effect.
Its application in makeup:
Radix Notoginseng extract has the effect of suppression in mouse subcutaneous injection squadron toes edema, also restraining effect is had to silver kb receptor activation, this is an index of reflection anti-inflammatory power, therefore Radix Notoginseng extract is according to anti-inflammatory, Radix Notoginseng extract has promoter action to b-16 melanocyte activity, melanic growing amount can be increased, can be used for black based article, especially can Glycerin.
The nourishing function of concrete pseudo-ginseng, as follows:
1. vasodilation, reduce blood pressure, improve microcirculation, increase volume of blood flow, prevention and therapy heart and brain tissues ischemic, anoxia;
2. promote protein, Yeast Nucleic Acid, Synthesis of DNA, improve the health;
3. promote blood cell metabolism, balance adjustment blood cell;
4. two-ways regulation nervus centralis, improves mental, strengthens learning and memory ability;
5. enhancing body immunologic function, antitumor;
6. stop blooding, promoting blood circulation and removing blood stasis;
7. protect the liver, anti-inflammatory;
8. delay skin aging, nourishes skin;
9. two-ways regulation blood sugar, reduction blood fat, cholesterol, suppression arteriosclerosis.
But, there is not practical application pseudo-ginseng being made an addition to perfumed soap in prior art.
Summary of the invention:
For prior art above shortcomings, technical problem to be solved by this invention is to provide a kind of Pseudo-ginseng low-irritation skin care soap.
Technical problem of the present invention, is achieved by following technical proposals:
A kind of Pseudo-ginseng low-irritation skin care soap, comprises the raw material of following weight part: Radix Notoginseng extract 0.05-0.15 part, sodium laurate 15-25 part, Sodium tetradecanoate 50-70 part, dodecanamide propyl amine oxide 3-5 part, myristic amide propyl group amine oxide 3-5 part, 20 parts, water.
Preferably, a kind of Pseudo-ginseng low-irritation skin care soap, comprise the raw material of following weight part: Radix Notoginseng extract 0.05-0.15 part, sequestrant 0.5-1.5 part, dodecanamide propyl amine oxide 3-5 part, myristic amide propyl group amine oxide 3-5 part, sodium laurate 15-25 part, Sodium tetradecanoate 50-70 part, 20 parts, water.
Described sequestrant is disodium EDTA, tetrasodium salt of EDTA, ethylenediamine tetramethylene phosphonic acid, hydroxymethyl phosphonic acid diethyl ester, diethylenetriamine penta sodium, hexapotassium, two hexene triamine five methylenephosphonic acids, diethylenetriamine pentamethylenophosphonic acid(DTPP) seven sodium salt, EDTMP six sodium salt, sodium ethylenediamine tetramethylenephosphonate, one in methyl-glycine diacetate tri-sodium and hydroxyethyl diamine tetraacethyl trisodium salt or its mixture.
Optimally, described sequestrant, is made up of by weight following component: methyl-glycine diacetate tri-sodium 40-60 part and hydroxyethyl diamine tetraacethyl trisodium salt 40-60 part.
Below, simple declaration is made to part material involved in the present invention:
Radix Notoginseng extract of the present invention can pass through commercially available and obtain, as the Radix Notoginseng extract that Shenzhen BoDun spice Co., Ltd produces.This Radix Notoginseng extract also can adopt following method prepare and obtain: after pseudo-ginseng is pulverized, add the deionized water of 6-10 times of weight, soak 1-3 hour, ultrasonic extraction 10-15 minute, filter, centrifugal, discard precipitation by supernatant concentration, obtained Radix Notoginseng extract, controls Radix Notoginseng extract density at 1.05g/cm
3left and right.
Dodecanamide propyl amine oxide, CAS accession number: 61792-31-2, INCI title: LAURAMIDOPROPYLAMINE OXIDE.
Myristic amide propyl group amine oxide, CAS accession number: 67806-10-4.
Described methyl-glycine diacetate tri-sodium, CAS accession number: 170492-24-7, its English name: L-Alanine, N, N-bis (carboxymethyl)-, sodium salt (1:3).It has better biological degradability than conventional sequestrant EDTA, NTA, and under wider PH scope and high temperature, more stable, have higher calcium sequestration capacity, and have higher solubility property to inorganic sediment, heavy metal has good sequestering power.BASF AG is selected to produce in the present invention
m liquid.
Described hydroxyethyl diamine tetraacethyl trisodium salt, CAS accession number: 207386-87-6, its English name: Glycine, N-[2-[bis (carboxymethyl) amino] ethyl]-N-(2-hydroxyethyl)-, trisodium salt, hydrate (9CI).
In addition, in the present invention, other functional ingredient conventional in conventional toilet soaps can also be added, such as: antiseptic-germicide, pigment, essence, oxidation inhibitor, titanium dioxide etc., to realize corresponding function respectively.As added antiseptic-germicide, the antioxidant of 0.05-0.20 weight part, the sanitas of 0.02-0.2 weight part of 0.2-0.8 weight part on formula basis of the present invention, the essence of the titanium dioxide of 0.02-2 weight part, the white dyes of 0.001-0.05 weight part or 0.2-1.2 weight part.
Pseudo-ginseng low-irritation skin care soap of the present invention can adopt the general soapmaking step of industry conventional toilet soaps to be prepared, as:
A () kneads spice: taken in proportion in the kneading machine joining conventional soapmaking by the various raw materials of said components, knead and be uniformly mixed.
B () grinds: the material after being uniformly mixed kneading, enters in shredder, carries out soap body grinding.
(c) vacuum press strip: by the soap body after grinding, enter vacuum plodder, carry out vacuum press strip.
D () prints: the rectangular soap body that plodder extrudes directly enters printer and prints, and obtains shaping soap body.
Pseudo-ginseng low-irritation skin care soap of the present invention, foam exquisiteness is stable, and performance is gentle, low to the pungency of skin, after special interpolation Radix Notoginseng extract, more can moisten and protect skin.
Embodiment:
Embodiment further illustrates of the present invention below, instead of limit the scope of the invention.In the present invention, if no special instructions, each raw material all in working substance content for 100%.
Embodiment 1
Each raw material is taken by embodiment 1 data of table 1 correspondence.
A () kneads spice: joined in soap kneading machine by various raw material, knead and be uniformly mixed.
B () grinds: the material after being uniformly mixed kneading, enters in shredder, carries out soap body grinding.
(c) vacuum press strip: by the soap body after grinding, enter vacuum plodder, carry out vacuum press strip.
D () prints: the rectangular soap body that plodder extrudes directly enters printer and prints, and obtains shaping soap body.
Embodiment 2
Each raw material is taken by embodiment 2 data of table 1 correspondence.Perfumed soap is prepared by the method for embodiment 1.
Embodiment 3
Each raw material is taken by embodiment 3 data of table 1 correspondence.Perfumed soap is prepared by the method for embodiment 1.
Embodiment 4
Each raw material is taken by embodiment 4 data of table 1 correspondence.Perfumed soap is prepared by the method for embodiment 1.
Comparative example 1
Each raw material is taken by comparative example 1 data of table 1 correspondence.Perfumed soap is prepared by the method for embodiment 1.
Table 1: fancy soap formula list position: kilogram
| Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Comparative example 1 | |
| Radix Notoginseng extract | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Sodium laurate | 20 | 20 | 20 | 20 | 20 |
| Sodium tetradecanoate | 60 | 60 | 60 | 60 | 60 |
| Dodecanamide propyl amine oxide | 4 | 4 | 4 | 4 | / |
| Myristic amide propyl group amine oxide | 4 | 4 | 4 | 4 | / |
| α-lauryl alkyl betaine | / | / | / | / | 8 |
| Methyl-glycine diacetate tri-sodium | / | 1 | / | 0.5 | / |
| Hydroxyethyl diamine tetraacethyl trisodium salt | / | / | 1 | 0.5 | / |
| Water | 20 | 20 | 20 | 20 | 20 |
Test case 1:
Experiment soap lye concentration is 5wt%, and when consumption is 0.3ml, by HET VAM measurements determination skin reaction classification (relative values classification), intense stimulus > 2.0, stimulates 1.2-2.0, medium stimulation 0.8-1.2, minimal irritation 0.0-0.8.
Use Roche Latherometer to carry out foaming properties test, soap lye concentration is 2.5wt%, tests the foam height of 0 minute and 5 minutes respectively.
Table 2: test data table
The test data of experiment of associative list 2, the present invention selects nonionic surface active agent dodecanamide propyl amine oxide and myristic amide propyl group amine oxide built-up soap fundamental mode anion surfactant sodium laurate and Sodium tetradecanoate initiatively, effectively can reduce the pungency of perfumed soap; Select the composite interpolation of sequestrant methyl-glycine diacetate tri-sodium and hydroxyethyl diamine tetraacethyl trisodium salt initiatively, foaming power and the foam stability of perfumed soap can be promoted further.Above-mentioned difference technical characteristic did not have open in the prior art, was not common practise yet.
Claims (1)
1. a Pseudo-ginseng low-irritation skin care soap, it is characterized in that, comprise the raw material of following weight part: Radix Notoginseng extract 0.05-0.15 part, sequestrant 0.5-1.5 part, dodecanamide propyl amine oxide 3-5 part, myristic amide propyl group amine oxide 3-5 part, sodium laurate 15-25 part, Sodium tetradecanoate 50-70 part, 20 parts, water;
Described sequestrant, is made up of by weight following component: methyl-glycine diacetate tri-sodium 40-60 part and hydroxyethyl diamine tetraacethyl trisodium salt 40-60 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310096600.8A CN103666886B (en) | 2013-03-24 | 2013-03-24 | Pseudo-ginseng low-irritation skin care soap |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310096600.8A CN103666886B (en) | 2013-03-24 | 2013-03-24 | Pseudo-ginseng low-irritation skin care soap |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103666886A CN103666886A (en) | 2014-03-26 |
| CN103666886B true CN103666886B (en) | 2015-03-11 |
Family
ID=50305667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310096600.8A Active CN103666886B (en) | 2013-03-24 | 2013-03-24 | Pseudo-ginseng low-irritation skin care soap |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103666886B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104473799B (en) * | 2014-11-20 | 2018-04-27 | 云南人羞花化妆品有限公司 | A kind of pseudo-ginseng shower cream and preparation method thereof |
| CN107760490A (en) * | 2016-08-18 | 2018-03-06 | 广东中澔柏画健康药业有限公司 | A kind of pseudo-ginseng skin makeup soap of Chinese medicine preparation method for being advantageous to promoting blood circulation Whitening, spot |
| CN109825388A (en) * | 2019-01-28 | 2019-05-31 | 山东爸爸的选择健康科技有限公司 | A kind of massage, bacteriostasis soap and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1169466A (en) * | 1996-06-22 | 1998-01-07 | 云南省药物研究所制药厂 | Agent for bath in tub with functions of skin-beautifying, stimulating blood-circulation and causing muscles and joints to relax and sterilizing |
| CN102363740B (en) * | 2010-12-10 | 2012-09-12 | 江南大学 | Low-irritation and high-foaminess fancy soap formula |
-
2013
- 2013-03-24 CN CN201310096600.8A patent/CN103666886B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN103666886A (en) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101904908B (en) | Anti-hair loss traditional Chinese medicine composition, preparation method and application thereof to preparing anti-hair loss products | |
| CN102258442B (en) | Compound traditional Chinese medicine extract and application thereof to whitening, moisturizing and anti-aging skin care product | |
| CN103387894B (en) | Beautifying gynostemma pentaphylla composite perfumed soap | |
| CN102038626B (en) | Traditional Chinese medicinal hair-restoring and anti-alopecia shampoo and preparation method thereof | |
| CN107595735A (en) | A kind of amino acid cleansing breast containing folium artemisiae argyi and preparation method thereof | |
| CN103666886B (en) | Pseudo-ginseng low-irritation skin care soap | |
| CN105476950A (en) | Additive-free natural moisturizing foam face wash | |
| CN107913228A (en) | Containing ginger without silicone oil health-care shampoo and its preparation process | |
| KR20100074880A (en) | Shampoo composition for promoting restoring hair and preventing from losing hair | |
| CN103194342B (en) | Skin whitening platycodon root compound soap | |
| CN103666885B (en) | Herba rhodiolae low-irritation skincare fancy soap | |
| CN103666884B (en) | Sanguisorba antibacterial compound soap | |
| CN105560109A (en) | Shampoo salt with bacterium inhibiting and itch relieving efficacy, and preparation method thereof | |
| CN105476895A (en) | Shampoo composition with lotus active ingredients | |
| CN106473940A (en) | A kind of multiple-effect bath gel and preparation method thereof | |
| CN103361213B (en) | Asparagus fern whitening compound perfumed soap | |
| CN104083313A (en) | Facial mask capable of whitening, lightening spots and tendering skin | |
| CN103361209B (en) | Fructus cnidii inflammation diminishing compound perfumed soap | |
| CN103666887B (en) | Low-irritation aloe skin-care toilet soap | |
| CN105687050A (en) | Bath salt and preparation method | |
| CN103361210B (en) | Rehmannia oil-inhibiting compound perfumed soap | |
| CN103666888B (en) | Dandelion low-irritation skincare perfumed soap | |
| CN105687049A (en) | Bath salt capable of effectively removing face pimples and preparation method | |
| CN103565722A (en) | Application of composition of tremella aurantialba extract and tremella fuciformis extract in cosmetics | |
| CN103387896B (en) | Ginkgo leaf whitening composite perfumed soap |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Yue Inventor after: Li Tianyu Inventor after: Shou Jiaping Inventor after: Yang Shaojia Inventor before: Huang Meirong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG MEIRONG TO: CHEN YUE LI TIANYU SHOU JIAPING YANG SHAOJIA |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181218 Address after: 201111 E2128 first, 5500 Yuanjiang Road, Minhang District, Shanghai. Patentee after: Shanghai Yanzi Chemical Technology Co., Ltd. Address before: 201604 219, room 2, Lane 1000, Tower Road, Shek Hu Town, Songjiang District, Shanghai Patentee before: Shanghai Bafang Fine Chemical Engineering Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190919 Address after: 233010 Incubation Workshop, 414 Changle Road, Yuhui District, Bengbu City, Anhui Province Patentee after: Bengbu Xingshi Intellectual Property Operations Co., Ltd. Address before: 201111 Shanghai city Minhang District Yuanjiang Road No. 5500 building first room E2128 Patentee before: Shanghai Yanzi Chemical Technology Co., Ltd. |